Hester Biosciences Limited Q1, Q2, Q3, Q4, FY 2016-17, FY 2015-16 Standalone / Consolidated Results, Revenues, Net Profit, Tax, EPS, Live Chart …

Hester Biosciences Limited Company Profile :

Hester Biosciences Limited is an Indian company engaged in manufacturing of poultry vaccines and large animal vaccines, and trading of poultry health products and large animal health products.

Its product range includes vaccines, drugs, feed supplements and disinfectants. Its offerings include Avian, including Live B1, Live LAS, Live R2B, Live M48, Live FP, Gumboro M1, Gumboro I and Gumboro I+; swine fever vaccines, and large animal, including PPR Vaccine-Sungri 96 strain and Brucella abortus (S19) calf Vaccine.


Hester Biosciences ResultsBSE Code : 524669
NSE Symbol : HESTERBIO
ISIN No. : INE782E01017
Industry : Pharmaceuticals
Face Value : Rs.10.00


If you are an investor who has shares of Hester Biosciences or you are an stock market analyst then i am sure you might for Quarterly Results of Hester Biosciences.

In this article you will find Q1, Q2, Q3, Q4 and FY 2016-17 Results of Hester Biosciences. That’s not all, you can compare those results with previous year i.e., FY 2015-16 Results of Hester Biosciences.

Hester Biosciences Q1 Results 2016-17 :

Hester Biosciences will announce its Q1 FY 2016-17 Results in the month of July 2016. We will update the table below once the results are announced.

(Values in Cr.) Q1 Standalone Q1 Consolidated
Revenue
Other Income  –
Total Income  –
Expenditure  –
Interest  –
Depreciation  –
PBT  –
Tax  –
Net Profit  –
Equity  –
EPS  –

Hester Biosciences will announce its Q2 FY 2016-17 Results in the month of October 2016.

(Values in Cr.) Q2 Standalone Q2 Consolidated
Revenue
Other Income  –
Total Income  –
Expenditure  –
Interest  –
Depreciation  –
PBT  –
Tax  –
Net Profit  –
Equity  –
EPS  –

Hester Biosciences will announce its Q3 FY 2016-17 Results in the month of January 2017.

(Values in Cr.) Q3 Standalone Q3 Consolidated
Revenue
Other Income  –
Total Income  –
Expenditure  –
Interest  –
Depreciation  –
PBT  –
Tax  –
Net Profit  –
Equity  –
EPS  –

Hester Biosciences will announce its Q4 FY 2016-17 Results in the month of April 2017.

(Values in Cr.) Q4 Standalone Q4 Consolidated
Revenue
Other Income  –
Total Income  –
Expenditure  –
Interest  –
Depreciation  –
PBT  –
Tax  –
Net Profit  –
Equity  –
EPS  –

Hester Biosciences will announce its FY 2016-17 Results in the month of April 2017.

(Values in Cr.) FY 2016-17 Standalone FY 2016-17 Consolidated
Revenue
Other Income  –
Total Income  –
Expenditure  –
Interest  –
Depreciation  –
PBT  –
Tax  –
Net Profit  –
Equity  –
EPS  –

Note : We will update the results table above as and when results are announced. Visit again.

Hester Biosciences Previous Year’s Results (FY 2015-16) :

(Values in Cr.) Standalone Consolidated
Revenue 100.89 100.89
Other Income  1.19  1.20
Total Income  102.09  102.09
Expenditure  -67.82  -74.04
Interest  -3.69  -3.71
Depreciation  -5.73  -5.75
PBT  24.85  24.33
Tax  -5.63  -5.62
Net Profit  19.22  18.70
Equity  8.51 8.51
EPS  22.60  22.20

Note : If you like this information about Hester Biosciences Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.